Johnson & Johnson
Sue provides strategic finance planning and management leadership and oversight to Johnson & Johnson Innovation as well as Business Development at the Janssen Pharmaceutical Companies of Johnson & Johnson.
Sue is a strong financial business partner and Credo-based leader who, throughout her tenure at Johnson & Johnson, has provided strategic financial counsel across the Pharmaceutical, Medical Device and Consumer Health sectors and Corporate Investor Relations. She also served as the J&J lead on an extensive 18-month journey with the Coalition for Inclusive Capitalism, exploring new ways to measure a company’s long-term value in cooperation with other multinational corporations, asset managers and asset owners.
Before joining Johnson & Johnson, Sue was an auditor for Arthur Andersen, LLP in Philadelphia, PA. Sue received her MBA from Villanova University and a Bachelor of Science degree in Accounting from La Salle University, where she currently serves as Treasurer on the Alumni Board. She is CPA licensed in the Commonwealth of Pennsylvania and a Certified Management Accountant.
Sue lives near Philadelphia with her husband and 3 teenagers and is an active member of the community where she lives. Her favorite non-work activities include spending time with her husband and children and some early morning runs to clear her mind for the challenges of each day.
This person is not in any offices
Johnson & Johnson
533 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.